4 Midcap High Growth Stocks to Watch for Future Multibagger Potential: Coforge, Max Healthcare, MCX and Dixon
- October 23, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Coforge Rs 1,908.80. Max Healthcare Rs 817. MCX Rs 3,113.70. Dixon Rs 11,594. Market caps from Rs 78,360 crore to Rs 86,393 crore. Data as of 22 Oct 2026.
Quick Answer
Coforge, Max Healthcare, MCX and Dixon are the 4 picks in this high growth stocks watchlist, with market caps between Rs 78,360 crore and Rs 86,393 crore. Coforge stands out for the largest market cap at Rs 86,393 crore, while Max Healthcare offers 18.82% revenue growth in FY26. PE ratios run from 37.64 to 57.24, so compare each one with its industry PE before investing. All figures are as of 22 October 2026.
High growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, Max Healthcare, MCX and Dixon meet that test, with market caps from Rs 78,360 crore to Rs 86,393 crore and Coforge offering the largest market cap at Rs 86,393 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 profit growth of at least 30 per cent and FY26 revenue growth of at least 15 per cent, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 profit growth of at least 30 per cent and FY26 revenue growth of at least 15 per cent, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening high growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 22 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are High Growth Stocks and Why Do They Attract Multibagger Interest?
High growth stocks are shares of mid sized companies that are growing both profit and sales at a fast pace. The four here cover IT services, hospitals, a commodity exchange and electronics manufacturing.
Fast growth from a mid sized base can lift earnings quickly when demand holds. For high growth stocks, both FY26 and the latest quarter showed growth. For high growth stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of high growth stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for high growth stocks before you decide.
High Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 22 October 2026. Dixon has the lowest PE of the group at 37.64, while MCX posts the highest return on equity at 46.75%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Coforge | 1,908.80 | 86,393 | 44.99 | 17.66 | 16.31% | 0.08 | 1,008.10 to 2,021.20 |
| Max Healthcare Institute | 817 | 83,403 | 57.24 | 60.75 | 13.42% | 0.32 | 817.00 to 1,221.90 |
| Multi Commodity Exchange of India | 3,113.70 | 80,621 | 52.29 | 42.17 | 46.75% | 0.00 | 1,762.10 to 3,481.40 |
| Dixon Technologies | 11,594 | 78,360 | 37.64 | 45.19 | 30.76% | 0.21 | 9,600.00 to 17,299.00 |
Coforge: 23.72% Profit CAGR Since FY22
Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.
In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 44.99 against an industry PE of 17.66, with a return on equity of 16.31%.
Max Healthcare: 24.26% Profit CAGR Since FY22
Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.
The stock trades at a PE of 57.24 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%. In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026.
MCX: 74.55% Profit CAGR Since FY22
MCX is India’s leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026. The stock trades at a PE of 52.29 against an industry PE of 42.17, with a return on equity of 46.75%.
Dixon: 71.44% Profit CAGR Since FY22
Dixon Technologies is an electronics manufacturing services company that makes televisions, phones, appliances and lighting for brands. It reported FY26 revenue of Rs 49,585.84 crore, up 27.53% year on year, and net profit of Rs 1,644.25 crore, up 33.40%. Net profit has compounded at 71.44% a year since FY22, while revenue has grown 46.72% a year. Operating margin was 3.95% in FY26. The debt-to-equity ratio is 0.21.
The stock trades at a PE of 37.64 against an industry PE of 45.19, below the sector average, with a return on equity of 30.76%. In the June 2026 quarter, revenue rose 25.23% to Rs 16,075.95 crore and net profit grew 156.35% to Rs 717.83 crore. The share price has gained 114.81% over five years.
High Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these high growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Coforge | 16,475.90 | 1,674.50 | 34.63% | 26.26% | 23.72% | 18.63% |
| Max Healthcare | 8,536.07 | 1,442.41 | 18.82% | 20.42% | 24.26% | 27.00% |
| MCX | 2,429.05 | 1,331.55 | 100.94% | 53.87% | 74.55% | 77.49% |
| Dixon | 49,585.84 | 1,644.25 | 27.53% | 46.72% | 71.44% | 6.43% |
Check the Univest Screener for live data on these high growth stocks
Institutional Holding in Coforge, Max Healthcare, MCX and Dixon
Institutional holding shows who is backing these high growth stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Coforge | Nil | 24.31% | 42.62% | 33.07% | June 2026 |
| Max Healthcare | 23.71% | 41.78% | 29.96% | 4.56% | June 2026 |
| MCX | Nil | 29.84% | 50.81% | 19.34% | June 2026 |
| Dixon | 28.50% | 18.96% | 28.71% | 23.83% | September 2026 |
Risks to Weigh in High Growth Stocks
Being careful with high growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Coforge trades at a PE of 44.99 against an industry PE of 17.66, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between High Growth Stocks
Picking from high growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (17.66 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Coforge, Max Healthcare, MCX and Dixon live prices.
Conclusion
Among high growth stocks, Coforge stands out for the largest market cap at Rs 86,393 crore, Max Healthcare for 18.82% revenue growth in FY26, MCX for the highest return on equity at 46.75% and Dixon for the strongest latest-quarter profit growth at 156.35%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on High Growth Stocks to Watch
Which are the best high growth stocks to watch for multibagger potential?
Ans. Coforge, Max Healthcare, MCX and Dixon are the 4 names this list highlights, with market caps of Rs 86,393 crore, Rs 83,403 crore, Rs 80,621 crore and Rs 78,360 crore respectively. Coforge is notable for the largest market cap at Rs 86,393 crore. Max Healthcare stands out for 18.82% revenue growth in FY26. MCX offers the highest return on equity at 46.75%. Dixon brings the strongest latest-quarter profit growth at 156.35%. These are watchlist names for high growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is MCX a good stock for long-term investors?
Ans. MCX has a return on equity of 46.75%, a PE of 52.29 against an industry PE of 42.17 and a market cap of Rs 80,621 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in high growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Dixon become a multibagger from here?
Ans. Dixon has already gained 114.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high growth stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 71.44% a year since FY22, and FY26 revenue rose 27.53%. At a PE of 37.64 against an industry PE of 45.19, valuation should be checked against that growth before investing.
What is the market cap of Coforge, Max Healthcare, MCX and Dixon?
Ans. As of 22 October 2026, Coforge has a market cap of Rs 86,393 crore, Max Healthcare has a market cap of Rs 83,403 crore, MCX has a market cap of Rs 80,621 crore and Dixon has a market cap of Rs 78,360 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high growth stocks.
What are the risks of investing in high growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 44.99 against an industry PE of 17.66, so earnings growth needs to hold up.
Why is Coforge trading at a PE of 44.99?
Ans. Coforge’s PE of 44.99 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in high growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Coforge, Max Healthcare, MCX and Dixon?
Ans. As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 71.74% of Max Healthcare (41.78% and 29.96%), 80.65% of MCX (29.84% and 50.81%) and 47.67% of Dixon (18.96% and 28.71%). Rising institutional holding is a useful signal in high growth stocks, though it should be read with earnings trends rather than on its own.
